ContraFect Corporation (CFRX:NASDAQ) soared at $1.94, a gain of 34.7%. On Fri, Jun 09, 2023, CFRX:NASDAQ touched a New 2-Week High of $1.94. The stock got featured on our News Catalysts scanner on Thu, Jun 08, 2023 at 05:17 PM in the 'MISCELLANEOUS' category. From Fri, May 26, 2023, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Mon, Apr 17, 2023 at $3.95 with a volume of 120M+.
About ContraFect Corporation (CFRX:NASDAQ)
ContraFect Corp is a biotechnology company engaged in the development of protein and antibody therapeutic products for life-threatening infectious diseases. The Company's product candidates are CF-301, CF-404.
Top 10 Gainers:
- Advanced Human Imaging Limited. (AHI:NASDAQ), 581.25%
- Blue Apron Holdings, Inc. (APRN:NYSE), 67.29%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 44.33%
- Sientra, Inc. (SIEN:NASDAQ), 42.53%
- Viveve Medical, Inc. (VIVE:NASDAQ), 40%
- Grom Social Enterprises Inc. (GROM:NASDAQ), 38.48%
- ContraFect Corporation (CFRX:NASDAQ), 34.72%
- Pharvaris N.V. (PHVS:NASDAQ), 32.36%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 25.28%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 25.17%